Related Experiment Videos
Tricuspid atresia: results of treatment in 160 children
Insights
Managing tricuspid atresia in 160 pediatric patients involves operative treatment within the first year. A management plan based on pulmonary blood flow, utilizing shunts and banding, offers good long-term palliation.
Area of Science:
- Pediatric Cardiology
- Congenital Heart Disease Management
- Surgical Palliation
Background:
- Tricuspid atresia is a complex congenital heart defect requiring early intervention.
- Management strategies vary based on pulmonary blood flow, necessitating tailored approaches.
- A significant number of affected children require surgical correction in infancy.
Purpose of the Study:
- To review the clinical management of 160 patients with tricuspid atresia.
- To simplify management by classifying patients based on pulmonary blood flow.
- To propose an effective long-term palliative strategy for tricuspid atresia.
Main Methods:
- Classification of patients according to total pulmonary blood flow (decreased vs. increased).
- Implementation of a staged surgical approach including Potts shunt and Glenn anastomosis for decreased flow.
- Consideration of pulmonary arterial banding for increased flow and transposition of the great arteries.
Main Results:
- A staged management plan, including Potts shunt followed by Glenn anastomosis, was applied to patients with decreased pulmonary flow.
- Pulmonary arterial banding was utilized for patients with increased pulmonary blood flow.
- Long-term palliative results for tricuspid atresia patients were found to be good.
Conclusions:
- A systematic approach to managing tricuspid atresia, categorized by pulmonary blood flow, simplifies clinical decision-making.
- Staged surgical palliation, with options like Potts shunt, Glenn anastomosis, and Fontan procedure, provides effective long-term outcomes.
- Early surgical intervention and tailored management plans are crucial for improving the prognosis of pediatric patients with tricuspid atresia.
Abstract:
Experience in managing 160 patients with tricuspid atresia is reviewed. The majority of these children require operative treatment in the 1st year of life. Clinical management of this rather complex anomaly is simplified by classifying each child according to total pulmonary blood flow. An overall plan of management for patients with decreased pulmonary flow is suggested. This consists of a Potts shunt as an initial procedure, limiting its anastomotic growth so that pulmonary flow becomes inadequate at age 10 to 12 years. A Glenn anastomosis is then constructed as the second procedue. The Fontan procedure should be considered carefully as an alternative to the Glenn anastomosis in these older children. Children with increased pulmonary blood flow and transposition of the great arteries are likely to require pulmonary arterial banding in infancy. Otherwise, patients in this smaller group are managed with the same overall plan. Results of long-term palliation have been good.